Obesogenic Medication Use in End-Stage Kidney Disease and Association With Transplant Listing. Orandi BJ, Li Y, Seckin T, Bae S, et al. Clin Transplant 2024;38:e15414.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Orandi BJ, Li Y, Seckin T, Bae S, et al. Obesogenic Medication Use in End-Stage Kidney Disease and Association With Transplant Listing. Clin Transplant 2024;38:e15414.
PMID: 39166467